TrialHuman vaccines & immunotherapeutics2020

Immunogenicity and safety of a dengue vaccine given as a booster in Singapore: a randomized Phase II, placebo-controlled trial evaluating its effects 5-6 years after completion of the primary series.

Juliana Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.